Tiny diamonds to boost treatment of chemoresistant leukemia

September 11, 2013

By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug to leukemic cells and retain the drug within the cells to combat the cancer.

This novel discovery, reported for the first time, addresses one of the major challenges in the treatment of leukemia where the cancer cells develop ways to pump drugs out of the body before they can do their job, particularly after they are exposed to chemotherapeutics.

Developed by Dr Edward Chow, Principal Investigator at the Cancer Science Institute of Singapore and Assistant Professor at the Department of Pharmacology, Yong Loo Lin School of Medicine at NUS, in collaboration with Professor Dean Ho of the UCLA School of Dentistry, this innovation shows promise for greater efficacy in treating leukemia, particularly in non-adherent cells.

The findings were first published online in the medical journal Nanomedicine: Nanotechnology, Biology, and Medicine.

When leukemia becomes drug-resistant

Daunorubicin is currently one of the most common drugs used to treat leukemia. The works by slowing down or stopping cancer cells from growing, causing many of them to die. It is also common, however, for leukemia to become resistant to this drug after treatment.

One mechanism by which this opposition, commonly known as chemoresistance, happens is through the expression of drug transporter pumps in that actively pump out chemotherapeutics, including Daunorubicin.

Innovative use of nanodiamonds

Current approaches to neutralising chemoresistance have centred on developing competitive inhibitors. These efforts have limited success, with challenges like high and less-than-promising results during clinical trials.

The team of scientists from NUS and UCLA turned to nanodiamonds, which are tiny, carbon-based particles that are 2 to 8 nanometers in diameter, as an option to address chemoresistance. Dr Chow studied the biological basis of how nanodiamonds can potentially overcome chemoresistance.

The scientists bound the surfaces of nanodiamonds with Daunorubicin, and the hybrid nanodiamond-drug complexes were introduced to leukemic cells. The research team found that nanodiamonds could carry the drug to the without being pumped out. Due to their non-invasive sizes and unique surface features, nanodiamonds can be easily released without blocking up blood vessels.

Dr Chow said, "The use of nanodiamonds offers a promising combination of biocompatibility and the capability to enhance therapeutic efficacy. Furthermore, our initial safety tests both in vitro and in vivo indicate that they are well tolerated which is a promising step towards continued translational development."

"Nanodiamonds are promising therapeutic vehicles, and one of our current goals is to determine which drugs would be optimally delivered by the nanodiamond towards specific disease models that would best benefit a patient in the future," added Prof Ho, who is with the Division of Oral Biology and Medicine and is also Co-Director of the Jane and Jerry Weintraub Center for Reconstructive Biotechnology at the UCLA School of Dentistry. Dr Ho is also a Professor of Bioengineering at UCLA.

Further research

The team noted that further development and safety evaluation of nanodiamond systems are necessary to realise their full potential. To further the research, the multi-disciplinary team of collaborators will be evaluating the drug-delivery complexes in clinical settings. They hope that their work can be translated into the clinic for use against that does not respond to Daunorubicin treatment. They are also look at applying the binding properties of nanodiamonds to other drugs.

Explore further: Nanodiamond Drug Device Could Transform Cancer Treatment

More information: Man, H. et al. Synthesis of nanodiamond–daunorubicin conjugates to overcome multidrug chemoresistance in leukemia, Nanomedicine: Nanotechnology, Biology, and Medicine, 3 August 2013. DOI: 10.1016/j.nano.2013.07.014

Related Stories

Nanodiamond Drug Device Could Transform Cancer Treatment

October 27, 2008

A team of investigators at Northwestern University has developed a promising nanomaterial-based biomedical device that could be used to deliver chemotherapy drugs locally to sites where cancerous tumors have been surgically ...

Nanodiamonds Advance Anticancer Gene Therapy

September 25, 2009

(PhysOrg.com) -- Gene therapy holds promise in the treatment of cancer as well as a large number of other diseases. However, developing a scalable system for delivering genes to cells both efficiently and safely has been ...

Game-changing nanodiamond discovery for MRI

January 14, 2010

A Northwestern University study shows that coupling a magnetic resonance imaging (MRI) contrast agent to a nanodiamond results in dramatically enhanced signal intensity and thus vivid image contrast.

Nanodiamonds take big step toward battling cancer

March 9, 2011

Chemotherapy drug resistance contributes to treatment failure in more than 90 percent of metastatic cancers. Overcoming this hurdle would significantly improve cancer survival rates.

Recommended for you

Reshaping the solar spectrum to turn light to electricity

July 28, 2015

When it comes to installing solar cells, labor cost and the cost of the land to house them constitute the bulk of the expense. The solar cells—made often of silicon or cadmium telluride—rarely cost more than 20 percent ...

Could stronger, tougher paper replace metal?

July 24, 2015

Researchers at the University of Maryland recently discovered that paper made of cellulose fibers is tougher and stronger the smaller the fibers get. For a long time, engineers have sought a material that is both strong (resistant ...

Changing the color of light

July 23, 2015

Researchers at the University of Delaware have received a $1 million grant from the W.M. Keck Foundation to explore a new idea that could improve solar cells, medical imaging and even cancer treatments. Simply put, they want ...

Wafer-thin material heralds future of wearable technology

July 27, 2015

UOW's Institute for Superconducting and Electronic Materials (ISEM) has successfully pioneered a way to construct a flexible, foldable and lightweight energy storage device that provides the building blocks for next-generation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.